Atlas Trials

Evaluation of Intravenous and Intraperitoneal Pharmacokinetics of Dalbavancin in Peritoneal Dialysis Patients

Clinical trial NCT02940730 · COMPLETED

Trial details

NCT number
NCT02940730
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Infectious Peritonitis
Start date
2017-05-01
Primary completion
2018-06-18
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.